Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 34 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/06
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 10/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/31/05
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 10/31/14
Due: 10/31/15
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 04/30/12
Due: 04/30/13
A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 11/16/21
End: 06/13/24
Due: 06/13/25
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 06/30/07
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 08/31/06
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 11/30/04
End: 01/31/11
Due: 01/31/12
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 04/30/13
End: 01/30/17
Due: 01/30/18
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 01/31/10
Due: 01/31/11
Phase: N/A
Priority: Normal
Start: 10/31/09
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 12/31/05
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 03/31/13
Due: 03/31/14
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 08/31/09
Due: 08/31/10
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 04/30/01
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/24/12
End: 11/04/13
Due: 11/04/14
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 10/31/11
Due: 10/31/12